AGP Executive Report
Last update: 3 hours agoBreast Cancer Care: A major international OPTIMA trial led by UCL finds many people over 40 with hormone-sensitive breast cancer can safely skip chemotherapy using a gene test (Prosigna), with similar five-year cancer-free survival and potentially fewer side effects. Alzheimer’s Screening: A Lancet study suggests a blood test measuring amyloid and tau biomarkers could flag Alzheimer’s risk decades before symptoms, linked to faster cognitive decline. Public Health & Lifestyle: A new look at “sitting as the new smoking” highlights long sitting time as a serious health risk, tied to higher death and heart-disease mortality in older women. Sweden Health Policy: Sweden’s smoke-free milestone (under 5% daily smokers) is reported alongside ongoing nicotine use concerns. Youth Mental Health: A summit by the Verdant Health Commission spotlights gaps in youth mental health care and the need for better family navigation and peer support. Healthcare Access & Costs: A policy discussion questions whether prescription drug affordability rules actually improve what older adults pay at the pharmacy counter.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
